论文部分内容阅读
目的:分析普米克令舒鼻腔雾化治疗上呼吸道感染后嗅觉障碍的临床疗效。方法:收集2013年1月—2014年12月在我院门诊进行治疗的上呼吸道感染后嗅觉障碍患者80例,随机分为治疗组和对照组,每组40例。对照组给予常规治疗,而治疗组患者在常规治疗基础上加用普米克令舒鼻腔雾化治疗,治疗结束后对比两组临床疗效。结果:治疗组临床总有效率为67.50%,而对照组临床总有效率为55.00%,治疗组临床总有效率显著高于对照组,差异具有统计学意义(P<0.05)。结论:普米克令舒鼻腔雾化治疗上呼吸道感染后嗅觉障碍临床疗效显著,可提高患者的生活质量,值得临床应用。
Objective: To analyze the clinical effect of pulmicort restenosis after nasal cavity inhalation on upper respiratory tract infection. Methods: Eighty patients with olfactory dysfunction after upper respiratory tract infection treated in our hospital from January 2013 to December 2014 were randomly divided into treatment group (n = 40) and control group (n = 40). The control group was given routine treatment, while the patients in the treatment group were treated with Pulmicort respules nasal nebulization on the basis of routine treatment. After the treatment, the clinical efficacy of the two groups were compared. Results: The total effective rate of the treatment group was 67.50%, while the total effective rate of the control group was 55.00%. The total effective rate of the treatment group was significantly higher than that of the control group (P <0.05). Conclusion: Pulmicort respirator Nasal cavity nebulization is effective in treating olfactory dysfunction after upper respiratory tract infection, which can improve the quality of life of patients and is worthy of clinical application.